Actinium Pharmaceuticals Inc (ATNM)

[ANESRI]

Actinium's Actimab-A phase 2 trial is currently open for recruitment at the following centers:

Center Location

UCLA Medical Center Los Angeles, California

University of Kentucky Lexington, Kentucky

University of Louisville Louisville, Kentucky

Ochsner Medical Center New Orleans, Louisiana

Weill Medical College of New York, New York

Cornell University

Columbia University New York, New York

Medical

Memorial Sloan Kettering New York, New York

Cancer Center

Duke Cancer Center Durham, North Carolina

University of Philadelphia,

Pennsylvania Pennsylvania

St. Francis Cancer Center Greenville, South

Carolina

Baylor Scott and White Dallas, Texas

Research Institute

Swedish Cancer Institute Seattle, Washington

Fred Hutchinson Cancer Seattle, Washington

Research Center

West Virginia University Morgantown, West Virginia

Medical College of Milwaukee, Wisconsin

Wisconsin Cancer Center

VA Caribbean Healthcare San Juan, Puerto Rico

System